|
81201-81203, 81292-81300, 81307, 81308, 81317-81319, 81321-81323, 81351, 81432, 81433, 81435, 81436, |
Heredigene Cancer Hereditary panel |
1482 |
25 - 35 days |
Comprehensive NGS analysis of 43 genes that are related to Hereditary Cancer Syndromes |
Hereditary Cancer Syndromes |
Blood in EDTA (2 vials X 2ml) |
43 |
germline |
|
81445, 81210, 81233, 81235, 81237, 81246, 81120, 81121, 81270, 81272, 81273, 81275, 81276, 81479, 81305, 81311, 81314, 81309, 81345, 81455 |
Mo.Re |
1980 |
15 - 20 days |
All solid tumors, NGS, multi-gene assay covers 147 genes and 51 fusion transcripts to provide an insight to the tumor biology to provide individualised treatment options. |
all solid tumors |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
161 |
somatic |
|
Please contact customer service |
Prime |
2620 |
15 - 20 days |
Comprehensive Genomic profiling based on DNA and RNA analysis for 500+ genes. Tissue in paraffin /3 unstained Sections 3μm & 5 unstained sections 10μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
all solid tumors |
Tissue in paraffin /3 unstained Sections 3μm & 5 unstained sections 10μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
513 |
somatic |
|
81210, 81235, 81275, 81276, 81301, 81311, 81309, 81352 |
Com.Pl.t.DX colon |
2426 |
10-18 days |
Colon Cancer Panel:24 gene+ 6 fusions panel +MSI. Somatic mutation detection from FFPE sample |
colon cancer |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
28 |
somatic |
|
81210, 81235, 81275, 81276, 81311, 81309, 81352 |
Com.Pl.t.DX lung |
2427 |
10-18 days |
Lung Cancer Panel: 24 gene+ 6 fusions panel. Somatic mutation detection from
FFPE samples |
Lung Cancer |
Tissue in paraffin /5 unstained Sections 3μm & 6 unstained sections 10μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
28 |
somatic |
|
81204 , 81210 , 81168 , 81235 , 81246 , 81120 , 81121 , 81272 , 81273 , 81275 , 81276 , 81311 , 81314 , 81309 , 81347 , 81455 , 81445 , 81479 , 81351 , 81352 , |
Com.pl.i.t DX Liquid Comprehensive |
2217 |
15 - 20 days |
NGS Analysis: 50 Genes and 12 Fusion Transcripts |
all solid tumors |
Whole Periferal Blood in DNA BCT and RNA BCT Streck tube |
50 |
somatic |
|
n/a |
Tumor Mutational Burden (TMB) |
2128 |
10-18 days |
NGS analysis |
agnostic marker (all solid tumors) |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
409 |
somatic |
|
n/a |
RET fusions |
2912 |
7 - 13 days |
NGS analysis |
lung, thyroid |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
n/a |
somatic |
|
81120, 81121, 88381 |
IDH 1/2 MUTATION |
1085 |
7 - 13 days |
NGS analysis |
Brain tumors / Acute Myeloid leukemia / cholangiocarcinoma |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
2 |
somatic |
|
81210 |
BRAF V600Eexon 11and 15 |
0208 |
10-18 days |
NGS analysis |
Melanoma, Colon Cancer and lung cancer |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
1 |
somatic |
|
81377(x1) , 88377 |
1p19q by Fluorescent in situ hybridization (FISH) |
2635 |
7 - 13 days |
Fluorescent In Situ Hybridization |
Brain tumors |
Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
n/a |
somatic |
|
81272 |
C-KIT gene exons 9, 11, 13, 17 |
0028 |
10-18 days |
NGS analysis |
on-label Gist tumors and off-label melanoma |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
1 |
somatic |
|
n/a |
EWS-WT1 - t(11;22) |
0541 |
7 - 13 days |
Fluorescent In Situ Hybridization |
Sarcoma |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
n/a |
somatic |
|
88377 |
N-MYC by Fluorescent in situ hybridization (FISH) |
1821 |
10 -18 days |
Fluorescent In Situ Hybridization |
Neuroblastoma |
Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
1 |
somatic |
|
88271 x2 , 88274 |
Her2/Neu by Fluorescent in situ hybridization (FISH) - (breast) |
2019 |
7 - 13 days |
Fluorescent In Situ Hybridization |
Breast CA |
Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
1 |
somatic |
|
88271 x2 , 88274 |
Her2/Neu by Fluorescent in situ hybridization (FISH) - (stomach) |
2019 |
7 - 13 days |
Fluorescent In Situ Hybridization |
Stomach CA |
Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
1 |
somatic |
|
81235 |
EGFR gene exons 18, 19, 20, 21 |
0030 |
10 -18 days |
NGS analysis |
Lung Cancer |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
1 |
somatic |
|
n/a |
EML4-ALK by Fluorescent in situ hybridization (FISH) |
1201 |
10 -18 days |
Fluorescent In Situ Hybridization |
Lung Cancer |
Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
n/a |
somatic |
|
n/a |
ROS-1 by Fluorescent in situ hybridization (FISH) |
1880 |
10 -18 days |
Fluorescent In Situ Hybridization |
Lung Cancer |
Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
n/a |
somatic |
|
88360 |
PD-L1 by IHC in Triple-
Negative Breast Carcinoma (TNBC) SP142 |
2250 |
7 - 13 days |
Immunohistochemistry analysis |
Triple Negative Breast Carcinoma |
Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
1 |
somatic |
|
88360 |
PD-L1 by IHC in Triple-
Negative Breast Carcinoma (TNBC) 22C3 |
2250 |
7 - 13 days |
Immunohistochemistry analysis |
Triple Negative Breast Carcinoma |
Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
1 |
somatic |
|
n/a |
PIK3CA gene, exons 9,13,17,20 |
1243 |
7 - 13 days |
NGS analysis |
All solid tumors (on-label indication for Breast CA) |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
1 |
somatic |
|
n/a |
PIK3CA gene Liquid Biopsy exons 9,13,17,20 |
2430 |
7 - 13 days |
NGS analysis |
All solid tumors (on-label indication for Breast CA) |
Whole Peripheral Blood in DNA BCT Streck tube |
1 |
somatic |
|
81275, 81276 |
K-RAS gene exons 2, 3, 4 |
1379 |
10 -18 days |
NGS analysis |
Colon Cancer and Lung Cancer |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
1 |
somatic |
|
81275, 81276 , 81311, 81210 |
K-RAS gene exons 2, 3, 4 &
NRAS gene exons 2, 3, 4/B_RAF exon 11,15 |
1380 |
10 -18 days |
NGS analysis |
Colon Cancer |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
3 |
somatic |
|
81311 |
N-RAS gene Exons 2,3,4, |
1244 |
10 -18 days |
NGS analysis |
Colon Cancer |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
1 |
somatic |
|
n/a |
Synovial Sarcoma |
0542 |
7 - 13 days |
NGS analysis fro translocation |
Synovial Sarcoma |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
2 |
somatic |
|
81162-81367, 81212, 81215, 81216, 81217 |
BRACA 1/2 somatic |
1676 |
10 -18 days |
Full Sequencing, via NGS of BRCA1 and BRCA2 genes |
on-label Ovarian CA. and Prostate CA Also Breast CA and Pancreatic |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
2 |
somatic |
|
81162-81367, 81212, 81215, 81216, 81217 |
BRCA1/2 full analysis Germ Line |
2037 |
15 - 20 days |
Full Sequencing, via NGS of BRCA1 and BRCA2 genes |
Hereditary Breast/Ovarian/pancreatic and Prostate Cancer |
Blood in EDTA (2 vials X 2ml) |
2 |
germline |
|
81217 |
MGMT methylation |
0395 |
10 -18 days |
Methylation specific Real - Time PCR |
Brain tumor |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
n/a |
somatic |
|
81210 |
BRAF gene exons 11 and 15 reflex |
1507 |
10 -18 days |
NGS analysis |
Melanoma, Colon Cancer and Lung CA |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
1 |
somatic |
|
81314 |
PDGFRA gene exams 12,14,18 |
1750 |
7 - 13 days |
NGS analysis |
Gist tumors |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
1 |
somatic |
|
n/a |
Single gene Liquid biopsy DNA |
1753 |
10 -18 days |
NGS analysis |
all solid tumors |
Whole Peripheral Blood in DNA BCT Streck tube |
1 |
somatic |
|
n/a |
Single gene Liquid biopsy RNA |
2073 |
10 -18 days |
NGS analysis |
all solid tumors |
Whole Peripheral Blood in RNA BCT Streck tube |
1 |
somatic |
|
81194 |
NTRK1,2,3 |
2239 |
7 - 13 days |
NGS analysis |
agnostic marker (all solid tumors) |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
n/a |
somatic |
|
81403, 81404, 81405 |
FGFR1, FGFR2, FGFR3 genes by NGS |
2646 |
10 -18 days |
NGS analysis |
cholagiocarcinoma (FGFR2 fusions on-label indication) and urothelial CA (on-label mutations) |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
3 plus fusions |
somatic |
|
n/a |
C-met exon 14 skipping mutations/amplification Liquid Biopsy |
3073 |
7 - 13 days |
NGS analysis |
Lung cancer |
Whole Peripheral Blood in DNA BCT |
1 |
somatic |
|
88381, 81301 |
Microsatellite instability (MSI) by NGS |
0025 |
7 - 13 days |
NGS analysis |
agnostic marker (all solid tumors) |
Tissue in paraffin/1 unstained Section 3μm and 4 unstained Sections 10μm |
|
somatic |
|
n/a |
PD-L1 |
|
7 - 13 days |
Immunohistochemistry analysis |
Immunotherapy marker (all solid tumors) |
Tissue in paraffin/5 unstained Sections 3μm: not baked & placed in the upper part of a (+) charged slide, no wrinkles |
1 |
somatic |
